Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells

Paolo Mellini, Biagina Marrocco, Diana Borovika, Lucia Polletta, Ilaria Carnevale, Serena Saladini, Giulia Stazi, Clemens Zwergel, Peteris Trapencieris, Elisabetta Ferretti, Marco Tafani, Sergio Valente, Antonello Mai

Research output: Contribution to journalArticlepeer-review

24 Scopus citations

Abstract

Novel pyrazole-based EZH2 inhibitors have been prepared through a molecular pruning approach from known inhibitors bearing a bicyclic moiety as a central scaffold. The hit compound 1o (N-((4,6-dimethyl-2-oxo-1,2-dihy-dropyridin-3-yl)methyl)-5-methyl-1-phenyl-1H-pyrazole-4-carboxamide) showed low micromolar EZH2/PRC2 inhibition and high selectivity towards a panel of other methyltransferases. Moreover, 1o displayed cell growth arrest in breast MDA-MB231, leukaemia K562, and neuroblastoma SK-N-BE cancer cells joined to reduction of H3K27me3 levels and induction of apoptosis and autophagy.

Original languageEnglish
Article number20170150
JournalPhilosophical Transactions of the Royal Society B: Biological Sciences
Volume373
Issue number1748
DOIs
StatePublished - Jun 5 2018
Externally publishedYes

Keywords

  • Apoptosis
  • Autophagy
  • Enhancer of zeste homologue 2 inhibitors
  • Epigenetics

Fingerprint

Dive into the research topics of 'Pyrazole-based inhibitors of enhancer of zeste homologue 2 induce apoptosis and autophagy in cancer cells'. Together they form a unique fingerprint.

Cite this